0001209191-21-055485.txt : 20210910 0001209191-21-055485.hdr.sgml : 20210910 20210910170849 ACCESSION NUMBER: 0001209191-21-055485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210802 FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galante Joseph C CENTRAL INDEX KEY: 0001632384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 211247766 MAIL ADDRESS: STREET 1: 111 TENTH AVENUE STREET 2: SUITE 200 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-02 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001632384 Galante Joseph C 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2021-08-02 4 P 0 142 3.34 A 34973 D Common Stock 2021-08-03 4 P 0 142 3.17 A 35115 D Common Stock 2021-08-04 4 P 0 142 3.18 A 35257 D Common Stock 2021-08-05 4 P 0 142 3.11 A 35399 D Common Stock 2021-08-06 4 P 0 142 3.01 A 35541 D Common Stock 2021-08-09 4 P 0 142 2.93 A 35683 D Common Stock 2021-08-10 4 P 0 142 2.96 A 35825 D Common Stock 2021-08-11 4 P 0 142 2.98 A 35967 D Common Stock 2021-08-13 4 P 0 142 2.92 A 36109 D Common Stock 2021-08-16 4 P 0 142 2.92 A 36251 D Common Stock 2021-08-17 4 P 0 142 3.05 A 36393 D Common Stock 2021-08-18 4 P 0 142 2.97 A 36535 D Common Stock 2021-08-19 4 P 0 142 3.02 A 36677 D Common Stock 2021-08-20 4 P 0 142 2.96 A 36819 D Common Stock 2021-08-23 4 P 0 142 2.87 A 36961 D Common Stock 2021-08-24 4 P 0 142 2.89 A 37103 D Common Stock 2021-08-25 4 P 0 142 2.79 A 37245 D Common Stock 2021-08-26 4 P 0 142 2.82 A 37387 D Common Stock 2021-08-27 4 P 0 142 2.84 A 37529 D Common Stock 2021-08-30 4 P 0 142 2.88 A 37671 D Common Stock 2021-08-31 4 P 0 142 2.93 A 37813 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. Joseph C. Galante by /s/ John Hamm as attorney-in-fact 2021-09-10